Doo-Sup Choi Selected Research

Nucleoside Transport Proteins (Nucleoside Transporter)

1/2018	Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal Model.
11/2013	Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.
8/2013	Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.
2/2011	Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Doo-Sup Choi Research Topics

Disease

27	Alcoholism (Alcohol Abuse) 01/2022 - 11/2002
9	Bipolar Disorder (Manic Depressive Psychosis) 11/2021 - 08/2014
8	Mental Disorders (Mental Disorder) 01/2020 - 12/2011
4	Schizophrenia (Dementia Praecox) 01/2022 - 01/2019
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 05/2016
4	Mania (Manias) 10/2019 - 12/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 05/2006
4	Ataxia (Dyssynergia) 09/2013 - 11/2008
3	Neuroinflammatory Diseases 09/2021 - 01/2019
3	Inflammation (Inflammations) 01/2019 - 04/2012
3	Ischemia 11/2013 - 07/2004
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Dyskinesias (Dyskinesia) 09/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 04/2021 - 01/2020
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2019
2	Obesity 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 01/2012
2	Psychomotor Agitation (Akathisia) 01/2018 - 05/2016
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 08/2017
2	Bulimia (Binge Eating) 01/2017 - 08/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2012
2	Infections 09/2012 - 10/2009
1	Pain (Aches) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Disease Progression 04/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Mood Disorders (Mood Disorder) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2017
1	Weight Gain 08/2017
1	Tobacco Use Disorder (Nicotine Dependence) 08/2017
1	Overweight 08/2017

Drug/Important Bio-Agent (IBA)

15	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 04/2010
14	Ethanol (Ethyl Alcohol)IBA 01/2021 - 11/2008
8	Glutamic Acid (Glutamate)FDA Link 01/2019 - 08/2010
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2006
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2009
5	Acamprosate (Campral)FDA Link 01/2022 - 02/2011
4	Protons (Proton)IBA 01/2019 - 07/2012
4	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 01/2018 - 02/2011
4	NucleosidesIBA 11/2013 - 04/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
3	CytokinesIBA 01/2021 - 04/2012
3	Equilibrative Nucleoside Transporter 1IBA 01/2017 - 01/2012
3	Ribavirin (Virazole)FDA LinkGeneric 09/2012 - 04/2009
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 08/2013
2	CatecholaminesIBA 01/2022 - 01/2021
2	Kynurenic Acid (Kynurenate)IBA 11/2021 - 01/2019
2	Levodopa (L Dopa)FDA LinkGeneric 09/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2019 - 10/2018
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 08/2010
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 03/2016 - 07/2012
2	Hypnotics and Sedatives (Sedatives)IBA 01/2014 - 01/2011
2	Peptides (Polypeptides)IBA 01/2014 - 05/2006
2	Dipyridamole (Persantine)FDA LinkGeneric 11/2013 - 08/2013
1	gadobutrolIBA 01/2022
1	gadoteridol (Prohance)FDA Link 01/2022
1	fibroblast growth factor 21IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2022
1	gadodiamide (Omniscan)FDA Link 01/2022
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 11/2021
1	Immunomodulating AgentsIBA 11/2021
1	G-Protein-Coupled Receptor KinasesIBA 11/2021
1	istradefyllineIBA 09/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 09/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	KynurenineIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	BenserazideIBA 01/2020
1	TenascinIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2020
1	Unithiol (DMPS)IBA 10/2019
1	LipopolysaccharidesIBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Excitatory Amino AcidsIBA 01/2019
1	Molecular Mechanisms of Pharmacological ActionIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	hepsinIBA 12/2017
1	lorcaserinIBA 08/2017
1	Varenicline (Chantix)FDA Link 08/2017
1	Tigecycline (Tygacil)FDA Link 01/2017
1	Excitatory Amino Acid Transporter 2IBA 01/2017
1	CorticosteroneIBA 01/2017
1	Nicotine FDA Link 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 05/2016

Therapy/Procedure

2	Therapeutics 10/2014 - 11/2002
1	Operative Surgical Procedures 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Intravenous Injections 01/2022
1	Precision Medicine 01/2017